Advertisement
Am J Health-Syst Pharm
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


American Journal of Health-System Pharmacy, Vol. 62, Issue 17, 1775-1781
Copyright © 2005 by American Society of Health-System Pharmacists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chisholm, M. A.
Right arrow Articles by Mulloy, L. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chisholm, M. A.
Right arrow Articles by Mulloy, L. L.

Report

Patient factors associated with adherence to immunosuppressant therapy in renal transplant recipients

Marie A. Chisholm, Charles E. Lance and Laura L. Mulloy

MARIE A. CHISHOLM, PHARM.D., FCCP, is Associate Professor of Pharmacy, College of Pharmacy, University of Georgia (UG), and Associate Clinical Professor of Medicine, School of Medicine, Medical College of Georgia (MCG), Augusta. CHARLES E. LANCE, PH.D., is Professor of Psychology, Applied Psychology Program, Department of Psychology, UG. LAURA L. MULLOY, D.O., FACP, is Professor of Medicine and Chief, Section of Nephrology, Hypertension and Transplantation Medicine, School of Medicine, MCG.

Address correspondence to Dr. Chisholm at the UGA Clinical Pharmacy Program, 1120 15th Street, CJ-1020, Medical College of Georgia, Augusta, GA 30912 (mchishol{at}mail.mcg.edu).


Purpose. Factors associated with adherence to immunosuppressant therapy (IST) in renal transplant recipients were studied.

Methods. The Immunosuppressant Therapy Adherence Scale (ITAS) was completed by adult renal transplant recipients in Georgia. Those completing the ITAS were classified as adherent to IST if their ITAS score were 12 and nonadherent if their score was less than 12. The relationship between the dichotomized ITAS scores and patient variables that are readily available to clinicians, such as sex, age, kidney donor type, income, marital status, race or ethnicity, and time since transplantation, was assessed. The relationship of ITAS scores to patients’ clinical and pharmacy data (e.g., graft rejection, serum IST concentrations, serum creatinine [SCr] concentrations, and pharmacy refill-based adherence rates) was also assessed.

Results. One hundred thirty-seven patients completed the ITAS. Eighty-nine patients (65%) were adherent to IST, and the remaining 48 (35%) were nonadherent. Patient sex was unrelated to adherence. Compared with nonadherent patients, adherent patients tended to be younger, to take cyclosporine, to have lower incomes, to have received their transplant more recently, to have targeted immunosuppressant concentrations, to have greater refill-based adherence rates, and to be less likely to exhibit an increase in SCr concentration (p < 0.05). There was no significant difference in the number of rejections between adherent and nonadherent patients.

Conclusion. Patient age, income, time since transplantation, and the immunosuppressant agent prescribed were associated with IST adherence.

Index terms: Age; Blood levels; Compliance; Cyclosporine; Graft rejection; Immunosuppressive agents; Patients; Sex; Sociology; Transplantation

 



This article has been cited by other articles:


Home page
Am J Health Syst PharmHome page
M. A. Chisholm-Burns, W. J. Kwong, L. L. Mulloy, and C. A. Spivey
Nonmodifiable characteristics associated with nonadherence to immunosuppressant therapy in renal transplant recipients
Am. J. Health Syst. Pharm., July 1, 2008; 65(13): 1242 - 1247.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M. A. Chisholm, G. M. Williamson, C. E. Lance, and L. L. Mulloy
Predicting adherence to immunosuppressant therapy: a prospective analysis of the theory of planned behaviour
Nephrol. Dial. Transplant., August 1, 2007; 22(8): 2339 - 2348.
[Abstract] [Full Text] [PDF]


Home page
Am J Health Syst PharmHome page
M. A. Chisholm, C. A. Spivey, and L. L. Mulloy
Effects of a medication assistance program with medication therapy management on the health of renal transplant recipients
Am. J. Health Syst. Pharm., July 15, 2007; 64(14): 1506 - 1512.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
G. J Burckart
Transplant Pharmacy: 30 Years of Improving Patient Care
Ann. Pharmacother., July 1, 2007; 41(7): 1261 - 1263.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
P. M. Stirnemann, S. K. Takemoto, M. A. Schnitzler, D. C. Brennan, K. C. Abbott, P. Salvalaggio, T. E. Burroughs, J. A. Gavard, L. M. Willoughby, and K. L. Lentine
Agreement of Immunosuppression Regimens Described in Medicare Pharmacy Claims with the Organ Procurement and Transplantation Network Survey
J. Am. Soc. Nephrol., August 1, 2006; 17(8): 2299 - 2306.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Society of Health-System Pharmacists.
Advertisement